162 related articles for article (PubMed ID: 8949314)
1. [Angiotensin converting enzyme inhibitors and ischemic heart diseases].
Bounhoure JP
Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():19-22. PubMed ID: 8949314
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
Pitt B
Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
[TBL] [Abstract][Full Text] [Related]
3. Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials.
Pepine CJ
Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-58-64. PubMed ID: 9422854
[TBL] [Abstract][Full Text] [Related]
4. Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function.
Pepine CJ
J Am Coll Cardiol; 1996 Apr; 27(5):1048-52. PubMed ID: 8609320
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
Tschudi MR; Noll G; Lüscher TP
Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition and vascular remodeling in coronary artery disease.
Adams KF
Coron Artery Dis; 1998; 9(10):675-84. PubMed ID: 9894619
[TBL] [Abstract][Full Text] [Related]
8. Effect of ACE inhibition on myocardial ischaemia.
Ferrari R
Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
[TBL] [Abstract][Full Text] [Related]
9. [Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
Landmark K; Aursnes I
Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1923-6. PubMed ID: 11488184
[TBL] [Abstract][Full Text] [Related]
10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Borghi C; Cosentino E; De Sanctis D
Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
[TBL] [Abstract][Full Text] [Related]
13. Effect of ACE inhibition on neurohormones.
Remme WJ
Eur Heart J; 1998 Sep; 19 Suppl J():J16-23. PubMed ID: 9796836
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
[TBL] [Abstract][Full Text] [Related]
15. [Action of converting enzyme inhibitors on myocardial ischemia and reperfusion injuries].
Galinier M; Bounhoure JP
Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():99-104. PubMed ID: 8304819
[TBL] [Abstract][Full Text] [Related]
16. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents.
Prisant LM
Am J Med; 2008 Aug; 121(8 Suppl):S8-15. PubMed ID: 18638617
[TBL] [Abstract][Full Text] [Related]
17. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
Wang AY; Li PK; Lui SF; Sanderson JE
Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
[TBL] [Abstract][Full Text] [Related]
19. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
Milicić D
Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
[TBL] [Abstract][Full Text] [Related]
20. [The significance of converting enzyme inhibitor angiotensin I to angiotensin II in treatment of patients with coronary disease].
Halawa B
Pol Merkur Lekarski; 1998 Jan; 4(19):32-4. PubMed ID: 9553407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
